Back to top
more

Myriad Genetics: (MYGN)

(Market Close from NSDQ)

 Add to portfolio

 ZacksTrade Now

$34.00 USD

34.00
792,576

+0.41 (1.22%)

Updated Apr 27, 2015 03:59 PM ET

Volume: 792,576

Open: $33.60

Prior Close: $33.59

Zacks Rank : 3-Hold [?]     3    

Style Scores [?] : Growth: B | Value: B | Momentum: A

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Sales 778 613 496 402 363
Cost Of Goods 109 80 65 47 44
Gross Profit 669 534 431 355 318
Selling & Adminstrative & Depr. & Amort Expenses 395 306 251 198 183
Income After Depreciation & Amortization 274 228 180 158 135
Non-Operating Income 3 5 4 2 6
Interest Expense 0 0 0 0 0
Pretax Income 278 233 185 160 141
Income Taxes 102 86 72 59 -11
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 176 147 112 101 152
Extras & Discontinued Operations 0 0 0 0 0
Net Income 176 147 112 101 152
Depreciation Footnote 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Income Before Depreciation & Amortization 288 237 189 165 142
Depreciation & Amortization (Cash Flow) 14 9 9 7 7
Income After Depreciation & Amortization 274 228 180 158 135
Earnings Per Share Data 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Average Shares 78.18 83.33 86.47 91.70 99.15
Diluted EPS Before Non-Recurring Items 2.43 1.77 1.30 1.10 1.39
Diluted Net EPS 2.25 1.77 1.30 1.10 1.54

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

3/31/15 12/31/14 9/30/14 6/30/14 3/31/14
Sales NA 184.39 168.84 188.77 182.92
Cost Of Goods NA 37.85 34.87 30.98 26.61
Gross Profit NA 146.54 133.97 157.79 156.32
SG&A, R&D, and Dept/Amort Expenses 0.00 110.20 108.05 104.54 101.03
Income After SG&A, R&D, and Dept/Amort Expenses 0.00 36.34 25.92 53.25 55.29
Non-Operating Income NA 1.60 -0.04 -0.70 2.06
Interest Expense NA 0.00 0.00 0.00 0.00
Pretax Income NA 37.94 25.88 52.55 57.34
Income Taxes NA 13.91 9.90 18.92 20.57
Minority Interest NA 0.00 0.00 0.00 0.00
Investment Gains/Losses NA 0.00 0.00 0.00 0.00
Other Income/Charges NA 0.00 0.00 0.00 0.00
Income From Cont. Operations NA 24.03 15.98 33.63 36.77
Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
Net Income NA 24.03 15.98 33.63 36.77
Earnings Per Share Data 3/31/15 12/31/14 9/30/14 6/30/14 3/31/14
Average Shares NA 75.40 76.09 77.68 76.37
Diluted EPS Before Non-Recurring Items NA 0.40 0.25 0.48 0.60
Diluted Net EPS NA 0.32 0.21 0.43 0.48
 

MYGN Chart by YCharts